Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatectomy | 12 | 2020 | 550 | 1.490 |
Why?
|
Hepatitis E | 3 | 2019 | 76 | 1.300 |
Why?
|
Liver Cirrhosis | 8 | 2019 | 1864 | 0.890 |
Why?
|
Liver Neoplasms | 16 | 2021 | 4252 | 0.890 |
Why?
|
Liver Transplantation | 15 | 2021 | 2118 | 0.850 |
Why?
|
Carcinoma, Hepatocellular | 13 | 2021 | 2214 | 0.840 |
Why?
|
Italy | 14 | 2021 | 832 | 0.760 |
Why?
|
Gastrointestinal Stromal Tumors | 6 | 2020 | 643 | 0.640 |
Why?
|
Bile Ducts | 2 | 2017 | 284 | 0.580 |
Why?
|
Foodborne Diseases | 1 | 2016 | 39 | 0.560 |
Why?
|
Cholelithiasis | 1 | 2017 | 411 | 0.550 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2017 | 230 | 0.540 |
Why?
|
Echinococcosis | 1 | 2015 | 30 | 0.530 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 504 | 0.510 |
Why?
|
Cholestasis | 1 | 2017 | 378 | 0.490 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 4 | 2020 | 379 | 0.470 |
Why?
|
Hepatitis E virus | 3 | 2019 | 71 | 0.430 |
Why?
|
Acute Kidney Injury | 3 | 2019 | 1971 | 0.420 |
Why?
|
Liver | 12 | 2021 | 7472 | 0.390 |
Why?
|
Hepatitis C, Chronic | 4 | 2021 | 1031 | 0.380 |
Why?
|
Gastrointestinal Neoplasms | 4 | 2019 | 989 | 0.380 |
Why?
|
Laparoscopy | 8 | 2020 | 2149 | 0.350 |
Why?
|
Hepacivirus | 4 | 2011 | 1379 | 0.310 |
Why?
|
Neoplasms, Connective and Soft Tissue | 2 | 2018 | 37 | 0.300 |
Why?
|
Ribavirin | 1 | 2009 | 395 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-kit | 3 | 2019 | 774 | 0.280 |
Why?
|
End Stage Liver Disease | 2 | 2021 | 314 | 0.260 |
Why?
|
Chondrosarcoma | 2 | 2018 | 309 | 0.260 |
Why?
|
Interferon-alpha | 1 | 2009 | 895 | 0.240 |
Why?
|
Pancreatic Neoplasms | 5 | 2023 | 5257 | 0.230 |
Why?
|
Bile Duct Neoplasms | 2 | 2020 | 567 | 0.220 |
Why?
|
Cholangiocarcinoma | 2 | 2020 | 516 | 0.220 |
Why?
|
Antiviral Agents | 2 | 2021 | 2987 | 0.220 |
Why?
|
Tissue and Organ Procurement | 2 | 2022 | 897 | 0.220 |
Why?
|
Immunocompromised Host | 2 | 2019 | 847 | 0.220 |
Why?
|
Robotics | 3 | 2019 | 899 | 0.210 |
Why?
|
Benzenesulfonates | 2 | 2011 | 169 | 0.190 |
Why?
|
Pancreatectomy | 2 | 2018 | 804 | 0.190 |
Why?
|
Transcription Factor RelA | 1 | 2021 | 275 | 0.180 |
Why?
|
Receptors, Steroid | 2 | 2018 | 155 | 0.180 |
Why?
|
Receptors, Thyroid Hormone | 2 | 2018 | 202 | 0.180 |
Why?
|
Receptors, Glucocorticoid | 1 | 2021 | 302 | 0.180 |
Why?
|
Echinococcosis, Hepatic | 1 | 2019 | 24 | 0.180 |
Why?
|
Fibroblast Growth Factor 4 | 1 | 2019 | 27 | 0.170 |
Why?
|
Exons | 3 | 2020 | 2439 | 0.170 |
Why?
|
HELLP Syndrome | 1 | 2019 | 41 | 0.170 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2023 | 1368 | 0.170 |
Why?
|
Renal Dialysis | 3 | 2019 | 1787 | 0.170 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5670 | 0.160 |
Why?
|
Surgery, Computer-Assisted | 2 | 2018 | 1018 | 0.160 |
Why?
|
Immunoglobulin M | 2 | 2016 | 1538 | 0.160 |
Why?
|
Middle Aged | 38 | 2021 | 213367 | 0.160 |
Why?
|
Hepatitis, Chronic | 2 | 2016 | 52 | 0.160 |
Why?
|
Genotype | 5 | 2019 | 12956 | 0.160 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2017 | 41 | 0.160 |
Why?
|
Gene Duplication | 1 | 2019 | 330 | 0.150 |
Why?
|
INDEL Mutation | 1 | 2019 | 279 | 0.150 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2018 | 188 | 0.150 |
Why?
|
Retroperitoneal Fibrosis | 1 | 2017 | 37 | 0.150 |
Why?
|
Fibromatosis, Aggressive | 1 | 2018 | 118 | 0.150 |
Why?
|
Blood Loss, Surgical | 3 | 2019 | 661 | 0.150 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 2017 | 52 | 0.150 |
Why?
|
Transplants | 1 | 2019 | 209 | 0.150 |
Why?
|
3' Untranslated Regions | 1 | 2019 | 513 | 0.150 |
Why?
|
Mutant Proteins | 1 | 2019 | 500 | 0.140 |
Why?
|
Azacitidine | 1 | 2018 | 347 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2019 | 8426 | 0.140 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 291 | 0.140 |
Why?
|
Retrospective Studies | 17 | 2023 | 77426 | 0.140 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2018 | 224 | 0.140 |
Why?
|
Aged | 28 | 2023 | 163253 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2018 | 3598 | 0.140 |
Why?
|
Hepatitis Antibodies | 1 | 2016 | 73 | 0.140 |
Why?
|
Humans | 67 | 2024 | 744220 | 0.140 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2018 | 150 | 0.140 |
Why?
|
Male | 41 | 2023 | 350027 | 0.140 |
Why?
|
Hydronephrosis | 1 | 2017 | 269 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 388 | 0.140 |
Why?
|
Mushroom Poisoning | 1 | 2015 | 6 | 0.140 |
Why?
|
Length of Stay | 6 | 2019 | 6308 | 0.130 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2016 | 323 | 0.130 |
Why?
|
Postoperative Complications | 8 | 2019 | 15294 | 0.130 |
Why?
|
Brachial Artery | 1 | 2017 | 370 | 0.130 |
Why?
|
Melanoma | 2 | 2024 | 5475 | 0.130 |
Why?
|
Hospital Departments | 1 | 2015 | 137 | 0.130 |
Why?
|
Female | 42 | 2023 | 380197 | 0.130 |
Why?
|
Renal Veins | 1 | 2015 | 108 | 0.130 |
Why?
|
Luciferases | 1 | 2016 | 733 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 315 | 0.120 |
Why?
|
Sjogren's Syndrome | 1 | 2016 | 233 | 0.120 |
Why?
|
Liver Cirrhosis, Biliary | 2 | 2012 | 97 | 0.120 |
Why?
|
Luminescent Measurements | 1 | 2016 | 405 | 0.120 |
Why?
|
Aneurysm, False | 1 | 2017 | 276 | 0.120 |
Why?
|
Mycophenolic Acid | 1 | 2016 | 344 | 0.120 |
Why?
|
Nephritis, Interstitial | 1 | 2015 | 156 | 0.120 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2017 | 277 | 0.120 |
Why?
|
Sequence Deletion | 1 | 2018 | 1526 | 0.120 |
Why?
|
Radiosurgery | 1 | 2023 | 1328 | 0.110 |
Why?
|
Kidney Diseases, Cystic | 1 | 2015 | 186 | 0.110 |
Why?
|
Hemostasis, Surgical | 1 | 2014 | 128 | 0.110 |
Why?
|
beta Catenin | 1 | 2018 | 1059 | 0.110 |
Why?
|
Plant Extracts | 1 | 2016 | 472 | 0.110 |
Why?
|
Graft Survival | 2 | 2022 | 3740 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2013 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2017 | 601 | 0.110 |
Why?
|
Renal Artery | 1 | 2015 | 398 | 0.110 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2016 | 505 | 0.110 |
Why?
|
Adult | 26 | 2021 | 214035 | 0.110 |
Why?
|
Autoantibodies | 3 | 2012 | 2038 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1581 | 0.110 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 605 | 0.110 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 594 | 0.110 |
Why?
|
Ultrasonography, Interventional | 2 | 2018 | 1483 | 0.100 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 1940 | 0.100 |
Why?
|
Mutation | 5 | 2020 | 29784 | 0.100 |
Why?
|
Catheter Ablation | 3 | 2017 | 2758 | 0.100 |
Why?
|
Risk Management | 1 | 2015 | 571 | 0.100 |
Why?
|
Nephrology | 1 | 2015 | 263 | 0.100 |
Why?
|
Aneurysm | 1 | 2015 | 339 | 0.100 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 315 | 0.100 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 783 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1114 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4188 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 3 | 2023 | 1836 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2016 | 668 | 0.090 |
Why?
|
Postoperative Period | 1 | 2015 | 1841 | 0.090 |
Why?
|
Pancreatic Ducts | 1 | 2011 | 328 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.090 |
Why?
|
HIV Infections | 4 | 2021 | 16718 | 0.090 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 175 | 0.090 |
Why?
|
Pyridines | 2 | 2011 | 2822 | 0.090 |
Why?
|
Abdomen | 1 | 2015 | 1118 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1540 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2018 | 2563 | 0.080 |
Why?
|
Treatment Outcome | 11 | 2019 | 63119 | 0.080 |
Why?
|
Vena Cava, Inferior | 1 | 2011 | 436 | 0.080 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2008 | 93 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2018 | 2915 | 0.080 |
Why?
|
Fatty Liver | 3 | 2008 | 729 | 0.080 |
Why?
|
Leiomyosarcoma | 1 | 2011 | 477 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1789 | 0.070 |
Why?
|
Base Sequence | 1 | 2018 | 12801 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5169 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1831 | 0.070 |
Why?
|
Plasma Cells | 1 | 2010 | 591 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13409 | 0.070 |
Why?
|
Survival Rate | 5 | 2023 | 12781 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3703 | 0.070 |
Why?
|
Polycystic Kidney, Autosomal Recessive | 1 | 2005 | 32 | 0.070 |
Why?
|
Hepatomegaly | 1 | 2005 | 85 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2023 | 9230 | 0.070 |
Why?
|
MicroRNAs | 2 | 2019 | 3747 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1634 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2020 | 57768 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3646 | 0.060 |
Why?
|
Liver Diseases | 2 | 2021 | 1254 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 7730 | 0.060 |
Why?
|
Splenomegaly | 1 | 2005 | 190 | 0.060 |
Why?
|
Pancytopenia | 1 | 2005 | 104 | 0.060 |
Why?
|
Transglutaminases | 1 | 2005 | 194 | 0.060 |
Why?
|
Risk Factors | 5 | 2019 | 72280 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4553 | 0.060 |
Why?
|
Chemoembolization, Therapeutic | 2 | 2017 | 129 | 0.060 |
Why?
|
Prognosis | 6 | 2023 | 29050 | 0.060 |
Why?
|
Sirolimus | 1 | 2011 | 1563 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 6485 | 0.060 |
Why?
|
Polyethylene Glycols | 1 | 2009 | 1181 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2018 | 9647 | 0.060 |
Why?
|
Ultrasonography | 1 | 2015 | 5982 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 6 | 2017 | 20123 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8387 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10634 | 0.050 |
Why?
|
Validation Studies as Topic | 1 | 2021 | 159 | 0.050 |
Why?
|
GTP-Binding Proteins | 1 | 2005 | 970 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3523 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4929 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 2726 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2010 | 4559 | 0.050 |
Why?
|
Binding Sites | 2 | 2019 | 6116 | 0.040 |
Why?
|
Warm Ischemia | 1 | 2019 | 53 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 227 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39045 | 0.040 |
Why?
|
Stents | 1 | 2011 | 3280 | 0.040 |
Why?
|
Fibroblast Growth Factor 3 | 1 | 2019 | 17 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15525 | 0.040 |
Why?
|
Organ Preservation | 1 | 2022 | 331 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15538 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2023 | 1341 | 0.040 |
Why?
|
Neoplasm Staging | 2 | 2024 | 11007 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7183 | 0.040 |
Why?
|
Complement Inactivating Agents | 1 | 2019 | 50 | 0.040 |
Why?
|
Mitochondria | 1 | 2012 | 3520 | 0.040 |
Why?
|
Tissue and Organ Harvesting | 1 | 2022 | 369 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6612 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2019 | 146 | 0.040 |
Why?
|
Electron Transport Complex II | 1 | 2018 | 48 | 0.040 |
Why?
|
Prospective Studies | 3 | 2021 | 53280 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9438 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2019 | 417 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 250 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 2136 | 0.040 |
Why?
|
Celiac Disease | 1 | 2005 | 785 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12264 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1359 | 0.040 |
Why?
|
Learning Curve | 1 | 2019 | 208 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6893 | 0.040 |
Why?
|
Vitis | 1 | 2016 | 18 | 0.040 |
Why?
|
Equipment Design | 2 | 2016 | 3582 | 0.040 |
Why?
|
RNA-Binding Protein EWS | 1 | 2018 | 216 | 0.040 |
Why?
|
Groin | 1 | 2017 | 103 | 0.040 |
Why?
|
Retroperitoneal Space | 1 | 2017 | 172 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2021 | 4477 | 0.040 |
Why?
|
Child, Preschool | 2 | 2016 | 40992 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2018 | 2948 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 56436 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2021 | 1731 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19907 | 0.040 |
Why?
|
Immune System Diseases | 1 | 2019 | 263 | 0.040 |
Why?
|
Neoplasms | 2 | 2023 | 21672 | 0.030 |
Why?
|
Hospitals, University | 1 | 2018 | 571 | 0.030 |
Why?
|
Pancreas | 1 | 2023 | 1686 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2021 | 1118 | 0.030 |
Why?
|
Protein Stability | 1 | 2018 | 557 | 0.030 |
Why?
|
Amanita | 1 | 2015 | 2 | 0.030 |
Why?
|
Limit of Detection | 1 | 2016 | 265 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 21752 | 0.030 |
Why?
|
Laparoscopes | 1 | 2015 | 41 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13668 | 0.030 |
Why?
|
Microwaves | 1 | 2017 | 191 | 0.030 |
Why?
|
Alanine Transaminase | 2 | 2010 | 592 | 0.030 |
Why?
|
Time Factors | 4 | 2021 | 40063 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2021 | 2559 | 0.030 |
Why?
|
Karyotyping | 1 | 2016 | 1243 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1039 | 0.030 |
Why?
|
Dexamethasone | 1 | 2021 | 1948 | 0.030 |
Why?
|
Insulin Resistance | 1 | 2008 | 3863 | 0.030 |
Why?
|
Constriction | 1 | 2014 | 181 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2133 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1877 | 0.030 |
Why?
|
Adolescent | 4 | 2016 | 85759 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2021 | 4151 | 0.030 |
Why?
|
Cohort Studies | 4 | 2021 | 40559 | 0.030 |
Why?
|
ras Proteins | 1 | 2019 | 1060 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2501 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11493 | 0.030 |
Why?
|
Tissue Donors | 1 | 2022 | 2242 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 851 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1854 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2016 | 1547 | 0.030 |
Why?
|
Postpartum Period | 1 | 2019 | 1086 | 0.030 |
Why?
|
Patient Positioning | 1 | 2015 | 323 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2023 | 5974 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 871 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12244 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3203 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2108 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1782 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3300 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6773 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3509 | 0.030 |
Why?
|
Biopsy | 3 | 2010 | 6757 | 0.030 |
Why?
|
Genomics | 2 | 2018 | 5722 | 0.020 |
Why?
|
Child | 2 | 2016 | 77679 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6313 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 4012 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2649 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2389 | 0.020 |
Why?
|
Risk Assessment | 3 | 2018 | 23337 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2016 | 952 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
Gene Deletion | 1 | 2018 | 2751 | 0.020 |
Why?
|
Ethanol | 1 | 2017 | 1342 | 0.020 |
Why?
|
Hepatitis C | 2 | 2011 | 1591 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2246 | 0.020 |
Why?
|
HIV-1 | 2 | 2021 | 6938 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 2010 | 134 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1605 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1708 | 0.020 |
Why?
|
Niacinamide | 1 | 2011 | 416 | 0.020 |
Why?
|
Cholangitis | 1 | 2010 | 108 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5458 | 0.020 |
Why?
|
Vascular Patency | 1 | 2011 | 886 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7799 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2011 | 987 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2010 | 141 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2011 | 527 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4385 | 0.020 |
Why?
|
Cholangitis, Sclerosing | 1 | 2010 | 159 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3584 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6535 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4201 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2016 | 1582 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2008 | 528 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 865 | 0.020 |
Why?
|
Duodenoscopy | 1 | 2005 | 52 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3523 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7326 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9392 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10182 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3800 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6196 | 0.020 |
Why?
|
Postoperative Care | 1 | 2011 | 1485 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10250 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25043 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9582 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2005 | 418 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2008 | 11732 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2019 | 13036 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12355 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 21824 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 12075 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10480 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81178 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9728 | 0.010 |
Why?
|
Duodenum | 1 | 2005 | 483 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2018 | 3444 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16687 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2005 | 992 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5529 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13280 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12961 | 0.010 |
Why?
|
RNA, Viral | 1 | 2008 | 2902 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8628 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168788 | 0.010 |
Why?
|
Contrast Media | 1 | 2011 | 5300 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29142 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10396 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18367 | 0.010 |
Why?
|
Mass Screening | 1 | 2005 | 5252 | 0.010 |
Why?
|